AI-powered ECG analysis platform that detects cardiac dysfunction by layering machine learning onto standard heart electrical readings.
USD 0.09B revenue with 32.45% gross margin; company is unprofitable (USD -0.01B net income), burning cash on R&D and commercialization.
Early-stage AI algorithm and FDA clearance create near-term defensibility, but GE Healthcare, Philips, and Apple Watch are rapidly integrating cardiac AI into established distribution networks, eroding proprietary advantage.
Key events, in time order
Zcash-focused miner to take over combined entity led by CEO Andrea Childs; shares +49.2% premarket
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
